Company Description
Advanced Viral Research Corp.. The Group's principal activity is to produce, market, promote and sell pharmaceutical drugs. It is into organizational activities, research and development activities and raising capital. It operates under the ...
More
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
A
Breaking News
Reuters - November 18, 2009 1:15 PM
RICHMOND, Calif., Nov. 18 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that data from the University of Pennsylvania investigator sponsored Phase 1 safety study of Sangamo's zinc finger nuclease (ZFN) based product, ...
Reuters - November 12, 2009 9:38 AM
LUXEMBOURG & SAO PAULO, Brazil--(Business Wire)-- Advanced Biological Laboratories (ABL) and Centro de Genomas are pleased to announce an agency agreement whereby Centro de Genomas will provide to the private and public sectors throughout Brazil, the ABL ...
Forbes.com - November 12, 2009 9:20 AM
BusinessWire - Advanced Biological Laboratories (ABL) and Centro de Genomas are pleased to announce an agency agreement whereby Centro de Genomas will provide to the private and public sectors throughout Brazil, the ABL TherapyEdge products in Portuguese ...
Reuters - November 11, 2009 12:56 PM
LONDON, ON, Nov. 11 /PRNewswire/ - Viron Therapeutics Inc., a biopharmaceutical company pioneering the development of viral protein therapeutics, announced today that the Company's research collaborator, Dr. Jean-Claude Tardif, Director of the Research ...
Reuters - November 06, 2009 6:52 AM
RESEARCH TRIANGLE PARK, N.C., Nov. 6 /PRNewswire/ -- Chimerix, Inc., a biopharmaceutical company advancing orally-available antiviral therapeutics to address life-threatening diseases, presented updates on the development of the company's lead antiviral ...
